Two Sigma Securities’s ADMA Biologics ADMA Stock Holding History

Two Sigma Securities’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$153K	Buy	+16,994	New	+$268K	0.02%	1103
2025 Q3	–	Sell	-11,457	Closed	-$209K	–	1337
2025 Q2	$209K	Buy	+11,457	New	+$234K	0.03%	901
2023 Q4	–	Sell	-18,097	Closed	-$64.8K	–	2971
2023 Q3	$64.8K	Buy	18,097 +4,827	+36%	+$18.6K	﹤0.01%	2443
2023 Q2	$49K	Buy	+13,270	New	+$49.2K	﹤0.01%	2395
2023 Q1	–	Sell	-19,440	Closed	-$75.4K	–	2584
2022 Q4	$75.4K	Sell	19,440 -67,875	-78%	-$209K	﹤0.01%	2110
2022 Q3	$212K	Buy	+87,315	New	+$209K	0.01%	1902
2022 Q2	–	Sell	-11,184	Closed	-$20K	–	2164
2022 Q1	$20K	Sell	11,184 -10,320	-48%	-$16.1K	﹤0.01%	1978
2021 Q4	$30K	Buy	+21,504	New	+$28.3K	﹤0.01%	1357

Other funds holding ADMA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Two Sigma Securities's ADMA Position: Q1 2026 in Review

Two Sigma Securities opened a new position in ADMA Biologics (ADMA) in Q1 2026: 16,994 shares worth $153K. The stake represents 0.02% of the portfolio and ranks #1103 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ADMA as recently as Q2 2025.

Two Sigma Securities first reported a position in ADMA in Q4 2021 and has held it in 8 quarters since. The position peaked at $212K in Q3 2022. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

Two Sigma Securities held 16,994 shares of ADMA Biologics worth $153K as of Q1 2026.
ADMA Biologics was a new Two Sigma Securities position in Q1 2026.
ADMA Biologics made up 0.02% of Two Sigma Securities's portfolio in Q1 2026, its #1103 holding.
Two Sigma Securities first reported a position in ADMA Biologics in Q4 2021 and has held it in 8 quarters since.
Two Sigma Securities's ADMA Biologics position peaked at $212K in Q3 2022.
356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.